Incidence is increasing, with a current lifetime risk of 1 in 65 for invasive melanoma.
Melanoma is the third most common skin cancer, but is the most common cause of skin cancer-related death.
Up to 20% of patients develop metastatic disease.
The prognosis depends on the stage at diagnosis: 99% of patients with in-situ melanoma will be cured with simple excision, while less than 10% of patients with metastatic disease will live beyond 5 years.
Superficial spreading malignant melanoma
From the personal collection of Dr Hobart Walling and Dr Brian Swick.